(Q45351817)

English

Methotrexate/iatrogenic lymphoproliferative disorders in rheumatoid arthritis: histology, Epstein-Barr virus, and clonality are important predictors of disease progression and regression

scientific article published on 13 May 2013

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Methotrexate/iatrogenic lymphoproliferative disorders in rheumatoid arthritis: histology, Epstein-Barr virus, and clonality are important predictors of disease progression and regression (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Epstein–Barr virus

0 references

rheumatoid arthritis

1 reference

based on heuristic

inferred from title

lymphoproliferative disorders

1 reference

based on heuristic

inferred from title

author name string

Ayako Ichikawa

1

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Fumiko Arakawa

2

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Junichi Kiyasu

3

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Kensaku Sato

4

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Hiroaki Miyoshi

5

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Daisuke Niino

6

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Yoshizo Kimura

7

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Masanori Takeuchi

8

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Maki Yoshida

9

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Yukinao Ishibashi

10

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Shinji Nakashima

11

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Yasuo Sugita

12

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Osamu Miura

13

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Koichi Ohshima

14

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

publication date

13 May 2013

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

European Journal of Haematology

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

91

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

20-28

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1111%2FEJH.12116

21 January 2018

The effect of methotrexate and anti-tumor necrosis factor therapy on the risk of lymphoma in rheumatoid arthritis in 19,562 patients during 89,710 person-years of observation

1 reference

https://api.crossref.org/works/10.1111%2FEJH.12116

21 January 2018

Brief report: reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis

1 reference

https://api.crossref.org/works/10.1111%2FEJH.12116

21 January 2018

Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases

1 reference

https://api.crossref.org/works/10.1111%2FEJH.12116

21 January 2018

Improved PCR method for detecting monoclonal immunoglobulin heavy chain rearrangement in B cell neoplasms

1 reference

https://api.crossref.org/works/10.1111%2FEJH.12116

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1111%2FEJH.12116

21 January 2018

Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group

1 reference

https://api.crossref.org/works/10.1111%2FEJH.12116

21 January 2018

Distribution of malignant lymphoma in Japan: analysis of 2260 cases, 2001-2006.

1 reference

https://api.crossref.org/works/10.1111%2FEJH.12116

21 January 2018

Lymphoma subtypes in patients with rheumatoid arthritis: increased proportion of diffuse large B cell lymphoma

1 reference

https://api.crossref.org/works/10.1111%2FEJH.12116

21 January 2018

Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection

1 reference

https://api.crossref.org/works/10.1111%2FEJH.12116

21 January 2018

The anti-inflammatory action of methotrexate is not mediated by lymphocyte apoptosis, but by the suppression of activation and adhesion molecules

1 reference

https://api.crossref.org/works/10.1111%2FEJH.12116

21 January 2018

Reactivation of latent Epstein-Barr virus by methotrexate: a potential contributor to methotrexate-associated lymphomas

1 reference

https://api.crossref.org/works/10.1111%2FEJH.12116

21 January 2018

Epstein-Barr virus in B-cell non-Hodgkin's lymphomas: unexpected infection patterns and different infection incidence in low- and high-grade types

1 reference

https://api.crossref.org/works/10.1111%2FEJH.12116

21 January 2018

Immunodeficiency-associated lymphomas

1 reference

https://api.crossref.org/works/10.1111%2FEJH.12116

21 January 2018

Lymphomas in rheumatoid arthritis patients treated with methotrexate: a 3-year prospective study in France

1 reference

https://api.crossref.org/works/10.1111%2FEJH.12116

21 January 2018

Biology and treatment of Epstein-Barr virus-associated non-Hodgkin lymphomas

1 reference

https://api.crossref.org/works/10.1111%2FEJH.12116

21 January 2018

Immunotherapy for Epstein-Barr virus-associated tumors

1 reference

https://api.crossref.org/works/10.1111%2FEJH.12116

21 January 2018

Clinicopathologic correlations of diffuse large B-cell lymphoma in rheumatoid arthritis patients treated with methotrexate

1 reference

https://api.crossref.org/works/10.1111%2FEJH.12116

21 January 2018

Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation

1 reference

https://api.crossref.org/works/10.1111%2FEJH.12116

21 January 2018

Spontaneous remission of "methotrexate-associated lymphoproliferative disorders" after discontinuation of immunosuppressive treatment for autoimmune disease. Review of the literature

1 reference

https://api.crossref.org/works/10.1111%2FEJH.12116

21 January 2018

Successful treatment of immunodeficiency-associated EBV-negative lymphoproliferative disorders in rheumatoid arthritis by methotrexate withdrawal and prevention of its relapse by rituximab administration.

1 reference

https://api.crossref.org/works/10.1111%2FEJH.12116

21 January 2018

Clinical characteristics of post-transplant lymphoproliferative disorders.

1 reference

https://api.crossref.org/works/10.1111%2FEJH.12116

21 January 2018

Identifiers

10.1111/EJH.12116

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45351817&oldid=2075521363"